Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NUP160 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | HBA1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | SOX4 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | HBM | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | AKAP4 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | GRM2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | HBA2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | HDAC2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | ATG10 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | SEMA4A | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |